Cargando…
Redox regulation in tumor cell epithelial–mesenchymal transition: molecular basis and therapeutic strategy
Epithelial–mesenchymal transition (EMT) is recognized as a driving force of cancer cell metastasis and drug resistance, two leading causes of cancer recurrence and cancer-related death. It is, therefore, logical in cancer therapy to target the EMT switch to prevent such cancer metastasis and recurre...
Autores principales: | Jiang, Jingwen, Wang, Kui, Chen, Yan, Chen, Haining, Nice, Edouard C, Huang, Canhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661624/ https://www.ncbi.nlm.nih.gov/pubmed/29263924 http://dx.doi.org/10.1038/sigtrans.2017.36 |
Ejemplares similares
-
Redox homeostasis: the linchpin in stem cell self-renewal and differentiation
por: Wang, Kui, et al.
Publicado: (2013) -
Emerging role of tumor cell plasticity in modifying therapeutic response
por: Qin, Siyuan, et al.
Publicado: (2020) -
Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
por: Huang, Zhao, et al.
Publicado: (2022) -
Redox Control of the Dormant Cancer Cell Life Cycle
por: Li, Bowen, et al.
Publicado: (2021) -
An emerging master inducer and regulator for epithelial-mesenchymal transition and tumor metastasis: extracellular and intracellular ATP and its molecular functions and therapeutic potential
por: Cao, Yanyang, et al.
Publicado: (2023)